Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nahas, Stephanie J.
86  Ergebnisse:
Personensuche X
?
1

Sustained response to atogepant in episodic migraine: post ..:

Lipton, Richard B. ; Nahas, Stephanie J. ; Pozo-Rosich, Patricia...
The Journal of Headache and Pain.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Safety and tolerability of atogepant for the preventive tre..:

Rizzoli, Paul ; Marmura, Michael J. ; Robblee, Jennifer...
The Journal of Headache and Pain.  25 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Comparative efficacy, quality of life, safety, and tolerabi..:

Tassorelli, Cristina ; Onishchenko, Kateryna ; Halker Singh, Rashmi B....
Cephalalgia.  44 (2024)  2 - p. , 2024
Link: https://doi.org/10.1177/..
 
?
4

Persistence to anti-CGRP monoclonal antibodies and onabotul..:

Charleston IV, Larry ; Talon, Brian ; Sullivan, Christine...
The Journal of Headache and Pain.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

Optimized Acute Treatment of Migraine Is Associated With Gr..:

Buse, Dawn C. ; Nahas, Stephanie J. ; Stewart, Walter (Buzz) F....
Journal of Occupational & Environmental Medicine.  65 (2023)  4 - p. e261-e268 , 2023
Link: https://doi.org/10.1097/..
 
?
6

Benefit-risk assesment of atogepant: A post hoc anlysis of ..:

Nahas, Stephanie ; Ailani, Jessica ; Mcallister, Peter...
Journal of the Neurological Sciences.  455 (2023)  - p. 121632 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Risk factors for migraine disease progression: a narrative ..:

Lipton, Richard B. ; Buse, Dawn C. ; Nahas, Stephanie J....
Journal of Neurology.  270 (2023)  12 - p. 5692-5710 , 2023
Link: https://doi.org/10.1007/..
 
?
8

The Safety of Celecoxib as an Acute Treatment for Migraine:..:

Ailani, Jessica ; Nahas, Stephanie J. ; Friedman, Deborah I..
Pain and Therapy.  12 (2023)  3 - p. 655-669 , 2023
Link: https://doi.org/10.1007/..
 
?
9

Post Hoc Analysis of PROGRESS: Evaluating the Safety of Ato..:

Best, Patricia ; Harriott, Andrea ; Monteith, Teshamae...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
10

Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis o..:

Nahas, Stephanie ; Ailani, Jessica ; McAllister, Peter...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
11

Post hoc analysis of progress: Evaluating the safety of ato..:

Best, Patricia ; Harriott, Andrea ; Monteith, Teshamae...
Journal of the Neurological Sciences.  455 (2023)  - p. 121631 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Correction: Efficacy and safety of fremanezumab in clinical..:

Nahas, Stephanie J. ; Naegel, Steffen ; Cohen, Joshua M....
The Journal of Headache and Pain.  23 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
13

Monthly Migraine Days, Acute Medication Use Days, and Migra..:

Dodick, David W. ; Lipton, Richard B. ; Nahas, Stephanie J....
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
14

Changes in Heart Rate and Blood Pressure in Participants Tr..:

Naegel, Steffen ; Cohen, Joshua M. ; Kessler, Yoel...
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
?
15

Characterizing Pre-headache (Prodrome) Features of Migraine..:

Schwedt, Todd J. ; Nahas, Stephanie J. ; Fanning, Kristina M....
Neurology.  98 (2022)  18_supplement - p. , 2022
Link: https://doi.org/10.1212/..
 
1-15